ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Subclinical Rejection by Biopsy or Gene Expression Profile Predicts Long Term Kidney Function in Patients in the CTOT08 Trial

R. Heilman1, D. Taber2, K. Guo3, S. Brietigam3, j. charette3, S. Kurian4, M. Abecassis3, J. Friedewald3

1Mayo Clinic AZ, Scottsdale, AZ, 2MUSC, Charleston, SC, 3Northwestern University, Chicago, IL, 4Scripps, La Jolla, CA

Meeting: 2019 American Transplant Congress

Abstract number: A165

Keywords: Genomic markers, Glomerular filtration rate (GFR), Kidney transplantation, Protocol biopsy

Session Information

Session Name: Poster Session A: Biomarkers, Immune Monitoring and Outcomes

Session Type: Poster Session

Date: Saturday, June 1, 2019

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall C & D

*Purpose: The CTOT08 trial showed that either histological subAR or positive gene expression profile (GEP) in the blood associated with histological subAR correlated with a composite clinical endpoint (CCE) of adverse graft outcomes by 2 yrs post-Tx. Despite a trend, neither subAR nor +GEP was significantly associated with worse eGFR, one of the 3 components of the CCE. We hypothesized that longer follow-up would unmask such an association.

*Methods: Graft survival and eGFR (CKD-EPI) at last follow up were collected on available CTOT08 subjects. Subjects were divided into 3 groups based on serial paired (histology or GEP) samples: 1) no subAR or -GEP only, 2) mixed (subAR & no subAR) or (+ & – GEP), and 3) subAR or + GEP only. Cox proportional hazard model was used for analyzing graft survival, and Kruskal-Wallis rank sum test to detect differences in eGFR among groups.

*Results: Data were available from 3/5 sites with 216 (85%) of 253 subjects included in CTOT08 analyses. 23/216 (11%) grafts failed at a mean follow-up of 5.2 years (1898 days: range 74-2716) post-Tx with no difference in time to graft failure between groups by either histology or GEP (HR 1.29 group 3 vs group 1; 95% CI (0.42, 3.9); p-value 0.659). In contrast, we observed a statistically significant difference in mean eGFR at last follow up between the 3 groups whether classified by biopsy (p=0.026) or GEP (p=0.033) (Table).

*Conclusions: At a mean follow-up of 5.2 years post-Tx, histological subAR in the first 2 years correlates with similar rates of graft failure but statistically lower and clinically meaningful differences in eGFR compared to subjects without subAR. These data show an unmasking of statistical significance with longer follow-up signaled by an earlier trend in patients with either clinical or molecular evidence of subAR. These data demonstrate further clinical validity of both the clinical and molecular phenotype of subAR vs no subAR.

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Heilman R, Taber D, Guo K, Brietigam S, charette j, Kurian S, Abecassis M, Friedewald J. Subclinical Rejection by Biopsy or Gene Expression Profile Predicts Long Term Kidney Function in Patients in the CTOT08 Trial [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/subclinical-rejection-by-biopsy-or-gene-expression-profile-predicts-long-term-kidney-function-in-patients-in-the-ctot08-trial/. Accessed June 1, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences